Contact Us
Drug Search Results
More Filters [+]

MB-07133

Alternative Names: mb-07133, mb07133, mb 07133, mb-7133, mb 7133, mb7133
Latest Update: 2023-11-21
Latest Update Note: Clinical Trial Update

Product Description

MB07133 is being developed for the treatment of inoperable HCC, using a platform technology known as HepDirectTM, which enables drugs to be targeted specifically to the liver. (Sourced from: https://clinicaltrials.gov/ct2/show/NCT00073736)

Mechanisms of Action: DNA Polymerase Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Ligand
Company Location: SAN DIEGO CA 92121
Company CEO: John L. Higgins
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for MB-07133

Countries in Clinic: China, Unknown Location

Active Clinical Trial Count: 2

Highest Development Phases

Phase 2: Liver Cancer

Phase 1: Hepatocellular Carcinoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
CTR20200165

P2

Recruiting

Liver Cancer

None

CTR20160143

P1

Active, not recruiting

Hepatocellular Carcinoma

None

Recent News Events

Date

Type

Title

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions